1. Home
  2. MVBF vs RZLT Comparison

MVBF vs RZLT Comparison

Compare MVBF & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MVB Financial Corp.

MVBF

MVB Financial Corp.

HOLD

Current Price

$29.15

Market Cap

371.6M

Sector

Finance

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$4.91

Market Cap

420.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MVBF
RZLT
Founded
1997
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
371.6M
420.8M
IPO Year
2004
2011

Fundamental Metrics

Financial Performance
Metric
MVBF
RZLT
Price
$29.15
$4.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$29.50
$9.67
AVG Volume (30 Days)
47.1K
1.9M
Earning Date
04-29-2026
05-13-2026
Dividend Yield
2.63%
N/A
EPS Growth
34.64
26.32
EPS
0.39
N/A
Revenue
$3,400,000.00
N/A
Revenue This Year
$1.70
N/A
Revenue Next Year
$13.59
N/A
P/E Ratio
$73.44
N/A
Revenue Growth
51.92
N/A
52 Week Low
$22.14
$1.07
52 Week High
$30.23
$11.46

Technical Indicators

Market Signals
Indicator
MVBF
RZLT
Relative Strength Index (RSI) 55.14 53.68
Support Level $24.83 $2.91
Resistance Level $30.22 $5.42
Average True Range (ATR) 0.91 0.35
MACD -0.09 -0.02
Stochastic Oscillator 57.77 61.35

Price Performance

Historical Comparison
MVBF
RZLT

About MVBF MVB Financial Corp.

MVB Financial Corp is a financial holding company. The company provides a wide range of business activities through the Bank, commercial and retail banking services, as well as Fintech banking. It has three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of its revenue is generated from the CoRe Banking segment, which includes its Fintech division, represents banking products and services offered to customers by the Bank, loans and deposits accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: